INS and obesity due to melanocortin 4 receptor deficiency: In recent years, growing evidence has linked changes in gut microbiota with insulin sensitivity (Pedersen et al., 2016) and lipid metabolism (Kindt et al., 2018), and is now a target for obesity treatment (Maruvada et al., 2017).